The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
Open accessAbstract
Three closely related fungal metabolites, zaragozic acids A, B, and C, that are potent inhibitors of squalene synthase have been isolated and characterized. Zaragozic acids A, B, and C were produced from an unidentified sterile fungal culture, Sporormiella intermedia, and Leptodontium elatius, respectively. The structures of the zaragozic acids and their trimethyl esters were determined by a combination of physical and chemical techniques. The zaragozic acids are characterized by a novel 2,8-dioxobicyclo[3.2.1]octane-4,6,7- trihydroxyl-3,4,5-tricarboxylic acid core and differ from each other in the structures of the 6-acyl and 1-alkyl side chains. They were found to be potent competitive inhibitors of rat liver squalene synthase with apparent Ki values of 78 pM, 29 pM, and 45 pM, respectively. They inhibited cholesterol synthesis in Hep G2 cells, and zaragozic acid A was an inhibitor of acute hepatic cholesterol synthesis in the mouse (50% inhibitory dose of 200 micrograms/kg of body weight). Inhibition of squalene synthase in cells and in vivo was accompanied by an accumulation of label from [3H]mevalonate into farnesyl diphosphate, farnesol, and organic acids. These data indicate that the zaragozic acids are a previously unreported class of therapeutic agents with potential for the treatment of hypercholesterolemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberts, A. W., Chen, J., Kuron, G., Hunt, V, Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,628
Self-citationBiosynthesis of isoprenoid compounds
(1982) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(82)90284-5 · Cited by 552
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.
Baxter, A., Fitzgerald, B. J., Hutson, J. L., McCarthy, A. D., Motteram, J. M., Ross, B. C., Sapra, M., Snowden, M. A., Watson, N. S., & Williams, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49754-8 · Cited by 208
DAWSON, M. J., FARTHING, J. E., MARSHALL, P. S., MIDDLETON, R. F., O''NEILL, M. J., SHUTTLEWORTH, A., STYLLI, C., TAIT, R. M., TAYLOR, P. M., WILDMAN, H. G., et al. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.639 · Cited by 183
Molecular cloning and characterization of the yeast gene for squalene synthetase.
Jennings, S. M., Tsay, Y. H., Fisch, T. M., & Robinson, G. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6038 · Cited by 162
Sidebottom, P. J., Highcock, R. M., LANE, S. J., Procopiou, P. A., & Watson, N. S. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.648 · Cited by 154
NB-598: a potent competitive inhibitor of squalene epoxidase.
Horie, M., Tsuchiya, Y., Hayashi, M., Iida, Y., Iwasawa, Y., Nagata, Y., Sawasaki, Y., Fukuzumi, H., Kitani, K., & Kamei, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44716-8 · Cited by 108
Inhibition of hydroxymethylglutaryl-coenzyme A synthase by L-659,699.
Greenspan, M. D., Yudkovitz, J. B., Lo, C. Y., Chen, J. S., Alberts, A. W., Hunt, V. M., Chang, M. N., Yang, S. S., Thompson, K. L., & Chiang, Y. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7488 · Cited by 93
González‐Pacanowska, D., Arison, B. H., Havel, C. M., et al. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57300-8 · Cited by 59
Isoprenyl phosphinylformates: new inhibitors of squalene synthetase
Biller, S. A., Forster, C., Gordon, E. M., Harrity, T. W., Rich, L. C., Marretta, J., & Ciosek, C. P. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00110a024 · Cited by 57
Cited by
The maximal affinity of ligands
Kuntz, I. D., Chen, K., Sharp, K. A., & Kollman, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.9997 · Cited by 849
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
Kapadia, S. B., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409834102 · Cited by 511
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Systematic exploration of essential yeast gene function with temperature-sensitive mutants
Li, Z., Vizeacoumar, F. J., Bahr, S., Li, J., Warringer, J., Vizeacoumar, F. S., Min, R., VanderSluis, B., Bellay, J., DeVit, M., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1832 · Cited by 413
Cholesterol Biosynthesis: A Mechanistic Overview
Cerqueira, N. M. F. S. A., Oliveira, E. F., Gesto, D. S., Santos-Martins, D., Moreira, C., Moorthy, H. N., Ramos, M. J., & Fernandes, P. A. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00342 · Cited by 352
Metadata
- Authors
- Bergstrom, J. D., Kurtz, M. M., Rew, D. J., Amend, A. M., Karkas, J. D., Bostedor, R. G., Bansal, V. S., Dufresne, C., VanMiddlesworth, F. L., & Hensens, O. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-01
- Volume
- 90
- Issue
- 1
- Pages
- 80-84
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2162770644
- Cited by
- 335
- References
- 12
- FWCI
- 22.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. https://app.cochat.ai/papers/10.1073/pnas.90.1.80
- The paper
- Bergstrom, J. D., Kurtz, M. M., Rew, D. J., Amend, A. M., Karkas, J. D., Bostedor, R. G., Bansal, V. S., Dufresne, C., VanMiddlesworth, F. L., & Hensens, O. D. (1993). Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.90.1.80
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.